Kris De Boeck

Kris De Boeck

Auto-generated profile, based on publicly available information

Kris De Boeck

Pediatric Pulmonology, Department of Pediatrics, University of Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in Thorax
Verified
Journal Article
Open access
PDF file
KBK De Boeck
K De Boeck
MWM Wilschanski
M Wilschanski
CCC Castellani
C Castellani
CTC Taylor
C Taylor
HCH Cuppens
H Cuppens
MSM Sinaasappel
M Sinaasappel
There is great heterogeneity in the clinical manifestations of cystic fibrosis (CF). Some patients may have all the classical manifestations of CF from infancy and have a relatively poor prognosis, while others have much milder or even atypical disease manifestations and still carry mutations on each of the CFTR genes. It is important to distinguish between these categories of patients. The European Diagnostic Working Group proposes the following terminology. Patients are diagnosed with classic or typical CF if they have one or more phenotypic characteristics and a sweat chloride concentration of >60 mmol/l. The vast majority of CF patients fall into this category. Usually one established mutation causing CF can be identified on each CFTR gene. Patients with classic CF can have exocrine pancreatic insufficiency or pancreatic sufficiency. The disease can have a severe course with rapid progression of symptoms or a milder course with very little deterioration over time. Patients with non-classic or atypical CF have a CF phenotype in at least one organ system and a normal (<30 mmol/l) or borderline (30–60 mmol/l) sweat chloride level. In these patients confirmation of the diagnosis of CF requires detection of one disease causing mutation on each CFTR gene or direct quantification of CFTR dysfunction by nasal potential difference measurement. Non-classic CF includes patients with multiorgan or single organ involvement. Most of these patients have exocrine pancreatic sufficiency and milder lung disease. Algorithms for a structured diagnostic process are proposed.

1 April 2005 in Pediatrics
Verified
Journal Article
Closed access
PDF file
KBKris De Boeck
Kris De Boeck
MWMatijn Weren
Matijn Weren
MPMarijka Proesmans
Marijka Proesmans
EKEitan Kerem
Eitan Kerem
Objective. Pancreatitis is an infrequent complication among patients with cystic fibrosis (CF). It has mainly been reported for patients with pancreatic sufficiency (PS). Previous studies involved only a small number of patients because they contained data from single centers. The aim of this study was to evaluate the incidence of pancreatitis in a large heterogeneous CF population, to determine the relationship with pancreatic function, and to assess whether pancreatitis is associated with specific CFTR mutations.

1 June 2011 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
KBK. De Boeck
K. De Boeck
NDN. Derichs
N. Derichs
IFIsabelle Fajac
Isabelle Fajac
HJH.R. de Jonge
H.R. de Jonge
IBI. Bronsveld
I. Bronsveld
MWM. Wilschanski
M. Wilschanski

1 June 2004 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
KBK De Boeck
K De Boeck
AMA Malfroot
A Malfroot
LSL Van Schil
L Van Schil
PLP Lebecque
P Lebecque
CKC Knoop
C Knoop
BGBelgian Burkholderia cepacia Study Group
Belgian Burkholderia cepacia Study Group
In Belgian cystic fibrosis (CF) clinics, sputum samples are evaluated on selective MAST medium routinely every 3 months. In this study, in 1993 and 1999, isolates were further examined byrecArestriction fragment length polymorphism analysis and pulsed-field gel electrophoresis of genomic DNA restricted withSpeI.In 1993, 12 patients were colonised withBurkholderia cepaciacomplex (Bcc):B. cenocepacia(n=6),B. multivorans(n=3),B. stabilis(n=3). Four patients were colonised with the sameB. cenocepaciastrain; two with the sameB. stabilisstrain. After 5 yrs, threeB. cenocepacia- and oneB. multivorans-colonised patients had died.In 1999, Bcc was isolated in 12 patients:B. multivorans(n=9),B. stabilis(n=1) andB. cenocepacia(n=2). Three patients were colonised by the sameB. multivoransstrain. Compared to matched controls, the 5 yr outcome was poor; fourB. cepaciapatients died and none of the control patients died. Lung-function evolution was poor.In conclusion, the rate of colonisation in Belgian cystic fibrosis patients is stable and low.Burkholderia cenocepaciawas most prevalent in 1993;Burkholderia multivoransin 1999. The cross-infection rate is low. Three patients had transient colonisation. The impact ofBurkholderia cepaciacomplex on morbidity in the Belgian cystic fibrosis population is high and not limited toBurkholderia cenocepacia.

1 May 2005 in Thorax
Verified
Journal Article
Closed access
PDF file
KBK De Boeck
K De Boeck
MPM Proesmans
M Proesmans
LML Mortelmans
L Mortelmans
BBB Van Billoen
B Van Billoen
TWT Willems
T Willems
MJM Jorissen
M Jorissen
Background: A study was undertaken to assess the reliability of the nasal mucociliary transport test using 99mTc-albumin colloid as a screening test for primary ciliary dyskinesia (PCD) and to compare it with the gold standard nasal biopsy for study of ciliary motility and ultrastructure. Methods: During a 4 year period both tests were performed in 55 children referred with persistent or recurrent respiratory tract infections. Their median age was 4 years (range 1 month to 15 years). Results: The nasal biopsy results were as follows: PCD, n = 8; secondary ciliary dyskinesia (SCD), n = 19; normal, n = 28. The mucociliary transport test was abnormal in 29 patients (all 8 with PCD, 7/19 with SCD, and 14/28 with a normal biopsy). The sensitivity of the mucociliary transport test to diagnose PCD was therefore 100% (8/8) (95% exact confidence limits 63.06 to 100.00); the specificity was only 55% (26/47) (40.95 to 69.89). The negative predictive value was 100% (26/26) (86.77 to 100.00) and the positive predictive value was 28% (8/29) (12.37 to 47.24). Conclusion: Mucociliary transport is a non-invasive screening test that can be performed even in infants. The sensitivity of the test is high but its specificity is low. A normal test result excludes PCD.

24 June 2006 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
KBKris De Boeck
Kris De Boeck
FBFrans De Baets
Frans De Baets
AMAnne Malfroot
Anne Malfroot
KDKristine Desager
Kristine Desager
FMFrançoise Mouchet
Françoise Mouchet
MPMarijke Proesmans
Marijke Proesmans